MedTrace Logo

Immune Diversity Response to Oral Dosing of Nutritional Health Products in Healthy Participants

NCT05242718 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2022-02-16

No results posted yet for this study

Summary

A Phase IV, open-label, adaptive, 4-arm, multi-dose, single-centre, exploratory trial to assess the immune diversity response to oral administration of licensed Natural Health Products, in healthy adults, 60-70 years of age.

Conditions

  • Immunity Disorders

Interventions

DIETARY_SUPPLEMENT

N-Acetyl-L-cysteine (NAC)

Health Canada Natural Product Number (NPN) 80056946

DIETARY_SUPPLEMENT

Echinacea purpurea

Health Canada Natural Product Number (NPN) 80093896

DIETARY_SUPPLEMENT

Curcumin

Health Canada Natural Product Number (NPN) 80043455

DIETARY_SUPPLEMENT

Palmitoylethanolamide

Health Canada Natural Product Number (NPN) 80097472

Sponsors & Collaborators

  • Dicentra Inc.

    collaborator INDUSTRY

  • University of British Columbia

    collaborator OTHER

  • Immunoflex Therapeutics Inc.

    lead INDUSTRY

Principal Investigators

  • Gurinder Raj, MD · dicentra

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-10
Primary Completion
2021-05-01
Completion
2021-05-20

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05242718 on ClinicalTrials.gov